Đang chuẩn bị liên kết để tải về tài liệu:
An 8 week open-label interventional multicenter study to explore the lung clearance index as endpoint for clinical trials in cystic fibrosis patients ≥8 years of age, chronically infected with Pseudomonas aeruginosa

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Forced expiratory volume in 1 second (FEV1) is the only parameter currently recognized as a surrogate endpoint in cystic fibrosis (CF) trials. However, FEV1 is relatively insensitive to changes in the small airways of patients with milder lung disease. This pilot study aimed to explore the lung clearance index (LCI) as a marker for use in efficacy trials with inhaled antibiotics in CF. |

TÀI LIỆU LIÊN QUAN

An 8 week open-label interventional multicenter study to explore the lung clearance index as endpoint for clinical trials in cystic fibrosis patients ≥8 years of age, chronically infected with Pseudomonas aeruginosa

CSharp Week 8 DataSet XML

CSharp_Week 8: DataSet

Forex on Five Hours a Week: How to Make Money Trading on Your Own Time _8

Truyền thông số Digital Communication-Week 8

Principle Marketing - Week 8: Product

Lecture Introduction to software engineering: Week 8 - Nguyễn Thị Minh Tuyền

Lecture Introduction to software engineering - Week 8: UI Design

Lecture Microwave and Satellite Systems - Week 8: Satellite Orbit Mechanics

Lecture Data Structure and Algorithm - Week 8: Link List Data Structure
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.